CRP and cancer: However, most previous studies examining associations of CRP levels with incident CVD and cancer were based on one-time measurement.17-20 A drawback to this approach is that a single CRP measurement only provides “snapshot information” on the systemic inflammatory burden, which may be insufficient for adequate risk characterization.